Abstract
Intravascular imaging is an important tool in the arsenal of each interventional cardiologist. A multitude of imaging modalities are available to help understand coronary arterial and plaque morphology. While angiography provides a two-dimensional image of a three-dimensional structure, intravascular imaging enhances understanding by providing detailed cross-sectional images. The imaging modalities used often include intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT). Near-infrared spectroscopy (NIRS) is also available, although not widely used.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keyword
- Intracoronary
- Imaging
- Intravascular ultrasound
- IVUS
- Plaque
- Morphology
- Vessel size
- Optical coherence tomography
- OCT
- NIRS
Introduction
Intravascular imaging is an important tool in the arsenal of each interventional cardiologist. A multitude of imaging modalities are available to help understand coronary arterial and plaque morphology. While angiography provides a two-dimensional image of a three-dimensional structure, intravascular imaging enhances understanding by providing detailed cross-sectional images. The imaging modalities used often include intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT). Near-infrared spectroscopy (NIRS) is also available, although not widely used.
While IVUS imaging is based on ultrasound wave reflection, OCT is based on infrared light transmission and reflection through different tissues. Each of these two modalities has utility in diagnostic coronary angiography and percutaneous interventions, both for stable coronary artery disease (CAD) and in cases of acute coronary syndrome (ACS).
Intravascular Ultrasound (IVUS)
IVUS imaging technique has been available in clinical practice for a long time and is the most widely used and studied technique for intravascular imaging. First commercially available in the USA in the 1980’s, IVUS is increasingly being used in day-to-day practice [1].
Principle of IVUS Imaging
-
IVUS catheters use the principles of ultrasonic sound wave [20–45 Megahertz (MHz)], transmission and reflection. Sound waves, produced by a piezoelectric crystal in the IVUS catheter, propagate through the different tissues and are reflected according to the acoustic densities of each one of them.
-
Imaging with IVUS technique requires a special catheter to be inserted into the coronary arteries. There are two kinds of IVUS catheters available in the USA currently.
-
Phased Array Transducers:
-
Consist of multiple transducers arranged circumferentially that are activated sequentially to produce an image. For example, Eagle Eye imaging system from Philips Healthcare (Andover, Massachusetts, USA).
-
-
Single array (Mechanical) transducers:
-
Consist of a single transducer that rotates 360° to create images of the targeted vessel segment. For example: Opticross imaging catheters (Boston Scientific, Marlborough, Massachusetts, USA) and Kodama HD imaging catheter (Acist Medical Imaging, Eden Praire, Minnesota, USA).
-
-
-
The above-mentioned imaging systems use similar principles of image production and have similar axillary and longitudinal resolutions. Proprietary post-processing software is marketed by each individual company provides further improvement in image quality and definition.
Indications
-
IVUS imaging can be used in cases of acute coronary syndrome and stable coronary artery disease. Current guidelines recommend IVUS use in both pre-procedure planning and post-percutaneous intervention (PCI) stent optimization.
-
Pre-procedure planning:
-
Reference vessel sizing proximal and distal to the lesion.
-
Lesion characterization: Lesion complexity (e.g., plaque burden, calcification), and length, especially in bifurcations lesions.
-
To assess the need for lesion preparation/ modification.
-
Left main sizing, including assessing the significance of left main lesions. Class IIa, Level of Evidence: B [2]. Left main lumen area of 5.5 mm2 and non-left main area of 4 mm2 are considered significant for intervention.
-
Assessment of graft vasculopathy in transplanted hearts.
-
Assessment of Lesions with in-stent restenosis (ISR) needing evaluation for a mechanism of ISR. Class IIa, Level of Evidence: B [2].
-
Integral to performing no-contrast or ultra-low contrast percutaneous interventions in people with renal insufficiency [3].
-
-
Post-percutaneous intervention (PCI):
-
Optimizing stent placement by assessing for under expansion and malapposition.
-
Assess proximal and distal edge for geographical miss and dissection.
-
To assess for minimal stent area (MSA) post-implantation. MSA > 6 mm2 in non-left main vessels and MSA > 8.5 mm2 in left main lesions is considered ideal.
-
Image Characteristics
-
IVUS imaging has a resolution of 100–200 μm. It can help discriminate between the lumen–intima interface and, to a lesser degree, the interface between the media and intima.
-
The image is acquired as a gray scale (Fig. 9.1).
-
Virtual histology (VH) imaging incorporation and ChromaFlow (Eagle Eye catheter, Philips) can help with additional data, however, their interpretation is more specialized and can require advanced imaging experience.
Image Acquisition
-
Accurate IVUS image acquisition is essential for correct interpretation. Steps of IVUS imaging are as below.
-
Flush and prepare the IVUS catheter and connect to the imaging console.
-
Coronary artery engagement with the guide catheter. The guide catheter should be ≥5 French (Fr.)
-
Wiring of the desired coronary artery with a 0.014″ guidewire.
-
Flush and prepare the IVUS catheter with heparinized saline/ sterile normal saline.
-
Deliver the IVUS catheter past the targeted area of imaging. Most IVUS catheters are based on a 0.014″ monorail system.
-
Perform manual or mechanical pull back at a consistent speed of 1 m/ sec for imaging.
-
Live images are stored for post-processing and interpretation using vendor-specified software.
-
Remove the IVUS catheter and flush the guide catheter to remove any air from the “Y connector.”
-
Practical Considerations
-
Sheath Size: ≥5 French.
-
Anticoagulation: Therapeutic with Heparin or bivalirudin for ACT >250 s.
-
Administer 100–200 μg of intracoronary nitroglycerin prior to imaging.
-
Saline flushing may be needed to clear the vessel of artifact if using a mechanical IVUS catheter.
Limitations
-
Catheter deliverability across tortuous and calcified/ stenotic vessels.
-
Attenuation across calcified vessel segments.
-
Near field imaging is difficult with phased array transducers requiring image processing to clear the ring artifact.
-
Inter-observer variability in image interpretation.
Image Characteristic
Optical Coherence Tomography (OCT)
Optical coherence tomography (OCT) is an intravascular imaging technology for evaluating the cross-sectional and three-dimensional (3D) microstructure of blood vessels at a resolution of approximately 10 μm. It has been commercially available in the USA more recently and is gaining wider acceptance clinically. Abbott Vascular, Minneapolis, Minnesota, manufactures the current catheter (DragonFly OPTIS).
Principles of OCT Imaging
-
The OCT catheter utilizes near-infrared light for image acquisition. The lag time of optical echoes reflected or backscattered from subsurface structures in biological tissues helps in discriminating different coronary structures. OCT light source is in the near-infrared (NIR) range, typically with wavelengths of approximately 1.3 μm.
-
It has a resolution of nearly 10–20 μm, but tissue penetration is only 1–2 mm due to the short wavelength.
Indications
-
OCT and IVUS have overlapping indications in terms of coronary interventions. Some specific circumstances where we prefer OCT imaging to IVUS include plaque characterization and accurate assessment of post-PCI dissections.
-
Assessment of plaque morphology (e.g., plaque erosion in ACS) (Figs. 9.5 and 9.6).
-
Detection of edge dissections (Fig. 9.6). Major dissection defined as dissections >60° or ≥ 3 mm in length) [4].
-
Post-PCI stent optimization by exclusion stent malapposition. (Stent malapposition defined as a lumen to stent distance ≥200 μm) [4].
Image Characteristics
-
OCT images have a higher resolution than any other intracoronary imaging modality which allows for excellent tissue characterization as well as plaque detection. Therefore, OCT is the only imaging modality used to study/ characterize plaque erosion as an etiology of acute coronary syndromes.
-
Resolution of 10–20 μm.
-
3-D reconstruction by proprietary software provides real-time visualization of the lumen along different planes.
-
Computer-generated ‘rendering’ of stent helps identify areas of malapposition that are highlighted as yellow.
-
Automatic measurements of lumen and stent area, with special focus on the minimal stent/ lumen areas.
-
The target vessel needs to be cleared of blood to acquire images using OCT.
-
Universally used automatic pullback at about 25 mm/sec allows for accurate lesion length assessment.
-
Image Acquisition
-
Like any imaging, optimal image acquisition is the first step to accurate image interpretation. To avoid excessive contrast administration with repeated imaging attempts, a protocol based approach to OCT imaging is paramount.
-
Initiate with a sheath size of ≥6 French.
-
Therapeutic anticoagulation with heparin or bivalirudin for ACT >250 s.
-
Engage the target vessel and wire the lesion with a 0.014″ coronary guidewire.
-
Flush and prepare the OCT catheter with attached 3 cc syringe using undiluted contrast to purge air from the catheter.
-
Set the power injector according to the manufacturers’ instructions (typically at least 3 milliliters/ second (mL/sec) for a total volume of 12 mL for RCA and 4 mL/sec for a total volume of 14 mL for left coronaries with a pressure of no more than 450 PSI). Consider using a 20 mL syringe in case of manual injection.
-
Check catheter position and blood clearance from the vessel with a test injection.
-
Once assured of position, activate the imaging catheter (preferably with auto-pullback) and inject 100% contrast through the power injector.
-
Remove the imaging catheter from the coronary artery once the imaging pull back is complete.
-
Equipment and Practical Aspects
-
Sheath Size: ≥6 French. Avoid upsizing sheaths after therapeutic anticoagulation.
-
Administer 100–200 μg of intracoronary nitroglycerin prior to imaging.
-
The 4 P’s of successful OCT image acquisition are co-axial catheter positioning, setting up of Power injector, Purging the target vessel of blood, and enabling automated Pull back.
-
The length of the vessel acquired is about 75 mm, ensure the catheter is across the target lesion/ segment to be imaged.
-
Consider balloon predilation across tight stenosis for catheter delivery.
Limitations
-
Tissue penetration is limited, limiting clinical utility to non-left main lesions.
-
Left main and ostial right coronary arterial lesions are not satisfactorily imaged as the blood cannot be cleared adequately with contrast and tissue penetration is limited.
-
Catheter deliverability across tortuous and calcified/stenotic vessels.
-
Attenuation across lipid-rich plaques.
Image Characteristics
Comparing OCT vs IVUS
Intravascular imaging is now considered obligatory for most complex coronary cases, with proven mortality benefits in CTO and long lesions [5, 6].
-
The inherent differences in physical principles of either imaging modality (Table 9.1) provide a certain uniqueness to each technique’s utility in clinical practice.
-
IVUS has also been shown to increase the lumen gain/ post-dilation balloon sizing in various studies especially for complex lesions [5, 6].
-
High definition IVUS imaging with mechanical pull-back provides good quality images that help in the optimization of percutaneous interventions, including lesion length, calcification depth, and angle.
-
Each imaging modality has some specific scenarios where they are preferred as in Table 9.2.
-
An intimal thickness of >0.5 mm in proximal left anterior descending (LAD) is considered a marker for increased rates of major adverse cardiovascular outcomes [7].
-
OCT has a superior longitudinal and axial resolution.
-
There are well-defined objective definitions of stent malapposition (>200 microns) and major dissection (>60 degrees/ 3 mm) which can further decrease inter-observer variability in image interpretation [4].
-
Long-term follow-up for clinical outcomes is lacking but outcomes up to 24 months show decreased MACE rates with either imaging modality [10].
-
While there is significant, inter-observer variability in vessel sizing based on angiography alone, such disagreements can be overcome with intracoronary imaging [11].
-
It is of paramount importance that each practicing interventional cardiologist is familiar with the practical aspects of both imaging modalities, some of which are listed in Table 9.3.
Near-Infrared Spectroscopy (NIRS): Intravascular Ultrasound (IVUS) Imaging
The imaging system utilizes diffuse reflectance near-infrared spectroscopy (NIRS) , a classic method of analytical chemistry, to characterize the plaque for lipid content [13]. Diffuse reflectance spectroscopy requires scattering and absorption at different wavelengths of the light by the tissue.
How It Works
-
The combination of scattering and absorption of near-infrared light by organic molecules in the arterial wall and plaque produces a unique chemical signature.
-
An algorithm analyzes the detected signal for signs of cholesterol and provides automated lipid core-containing plaques (LCP) detection without the need for manual image processing (Fig. 9.8).
-
In contrast to OCT, NIRS can image through blood, as it does not need light to be directly reflected back to the detector [13].
Equipment
-
See Table 9.4 for equipment for TVC Insight catheter.
Indications
-
The Infraredx TVC Imaging SystemTM is intended for the detection of LCPs using NIRS and IVUS examination of the coronary arteries.
-
The combination of NIRS with IVUS in a single catheter combines the benefit of NIRS with the benefits of IVUS.
Limitations
-
NIRS–IVUS does not allow detection of non-superficial LCPs and LCPs in large vessels (more than 6 mm diameter) cannot visualize neovascularization.
NIRS–IVUS Numbers to Remember
-
Patient with stable coronary artery disease who undergoes PCI of lesions with large lipid core plaques (maxLCBI4 mm ≥500 by NIRS) is associated with a 50% risk of periprocedural MI and a maxLCBI4 mm >400 in the culprit segment is considered significant with STEMI [13, 14]. Statin therapy has been shown to decrease LCBI in lipid-rich plaque demonstrated by NIRS imaging [15].
-
Multimodality imaging: correlation of OCT and NIRS–IVUS imaging.
-
Combined utilization of OCT and NIRS–IVUS allows to characterize the microstructural features of plaque morphology, such as fibrous cap thickness and neovascularization (OCT) and plaque lipid content (NIRS), and perform robust quantitative measurements of the lumen, vessel, and plaque area (grayscale IVUS) in the same lesion (Table 9.5). Figure 9.9 shows an example of multimodality images of a thin-cap fibroatheroma lesion.
References
Islam YE, Ha LD, Ayman E, Gbolahan OO, Odunayo O, et al. Temporal trends in inpatient use of intravascular imaging among patients undergoing percutaneous coronary intervention in the United States. J Am Coll Cardiol Intv. 2018 May;11(9):913–5.
Glenn NL, Eric RB, James CB, Steven RB, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol. 2011 Dec;58(24):e44–e122.
José M, Cristiano G, Paulo S, Silvio Z, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (minimizing contrast utilization with IVUS guidance in coronary angioplasty) randomized controlled trial. J Am Coll Cardiol Intv. 2014;7(11):1287–93.
Ziad AA, Akiko M, Philippe G, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388(10060):2618–28.
Byeong K-K, Dong S-H, Myeong H-K, Hun P-S, Seung R-W, et al. Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation: randomized study. Circ Cardiovasc Interv. 2015;8:e002592.
Hong S, Kim B, Shin D, et al. Effect of intravascular ultrasound–guided vs angiography-guided Everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA. 2015;314(20):2155–63.
Jon AK, Jonathan MT, Randall CSE, Murat T, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45(9):1532–7.
So YC, Bernhard W, Akiko M, Alexandra JL, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv. 2011;4:239–47.
Alfonso F, Suárez A, Angiolillo DJ, et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart. 2004;90:1455–9.
Chirag B, Partha S, Saurav C, et al. Intravascular ultrasound–guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: meta-analysis of randomized trials. Am Heart J. 2017;185:26–34.
Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation. 1976;53:627–32.
Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (minimizing cOntrast utiliZation with IVUS guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014 Nov;7(11):1287–93.
Goldstein JA, Maini B, et al. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011;4(5):429–37.
Madder RD, Goldstein JA, et al. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2013;6(8):838–46.
Kini AS, Vengrenyuk Y, Shameer K, Maehara A, et al. Intracoronary imaging, cholesterol efflux, and transcriptomes after intensive statin treatment: the YELLOW II study. J Am Coll Cardiol. 2017 June;69(6):628–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Malhotra, R., Vengrenyuk, Y., Kini, A. (2021). Fundamentals of Intracoronary Imaging. In: Kini, A., Sharma, S.K. (eds) Practical Manual of Interventional Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-68538-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-68538-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-68537-9
Online ISBN: 978-3-030-68538-6
eBook Packages: MedicineMedicine (R0)